Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

A study by Vall d'Hebron shows the relationship between insomnia and ADHD improvement

These results contribute to improving the treatment of ADHD and insomnia, as well as to better understanding the interactions between these two complex disorders.

News

A novel and clinically validated optical biosensor enables rapid and quantitative serological testing of COVID-19

The new nano-biosensor for fast, quantitative and accurate COVID-19 serology achieves the high reliability of specialised laboratory analysis with the short times and simplicity of rapid self-tests.

News

Dos anys de recerca contra la Covid-19

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

News

L’exposició ‘L'altra mirada de la recerca’ comença la seva itinerància per diversos espais de Catalunya

La selecció d’imatges que forma la mostra ‘L’altra mirada de la recerca’ ha estat escollida entre les millors fotografies dels 11 anys del Concurs de Fotografia Científica del Campus Vall d’Hebron.

News

Assistència integral, recerca i la col·laboració de les associacions de pacients, claus per abordar les malalties minoritàries

Les malalties minoritàries són greus, poc freqüents i afecten 5 de cada 10.000 persones. N'hi ha més de 7.000, un 80% de les quals són d'origen genètic. Generalment impliquen diversos òrgans i afecten les capacitats físiques, les habilitats mentals i les qualitats sensorials i d

News

Almost 20 percent of patients who experience headache during COVID-19 develop chronic daily headache

When post-COVID-19 headache lasts for a month, there is a 50% change of it continuing for the next nine months.

News

Hepatology is the Service with the highest participation in clinical trials of liver diseases in Spain

The Hepatology Service is currently participating in 74 clinical trials, of which 50 are commercial.

News

A Vall d'Hebron study opens the door to personalized medicine in migraine

The results show that there are two types of migraine attacks depending on whether CGRP levels increase or not during the acute phase.

News

A new targeted nanosystem improves brain drug delivery for the treatment after a stroke

Direct brain administration through the carotid artery of nanomaterials carrying drugs that boost tissue recovery could be an effective method to reduce the undesirable effects in other organs and improve the arrival of the drug into the brain.

News

VHIR participates in the Tartaglia project: networked artificial intelligence to accelerate clinical and health research

The objective of the Tartaglia project will be to train mathematical models to support decision making and contribute to personalized and precision medicine.

News

Developing New Technologies & Diagnostic Tools for B-Cell Monitoring in Transplant Rejection

Vall d'Hebron has announced a research collaboration with Pure Transplant Solutions, LLC (PTS) led by Dr. Oriol Bestard, head of the Nephrology and Kidney Transplant group at VHIR.

News

Vall d’Hebron se suma al Dia Internacional del Càncer Infantil i referma l’aposta per la medicina personalitzada

Som centre estatal de referència per al trasplantament de progenitors hematopoètics o cèl·lules mare, amb 1.417 trasplantaments realitzats: fa una dècada que vam obtenir l’acreditació JACIE, la més prestigiosa de l’àmbit europeu.

News

Vall d’Hebron unveils a mural dedicated to female scientists

The artwork Pioneres, presented on the International Day of Women and Girls in Science, is almost 40 metres long and portrays nine women, from Ancient Greece to the present day, who have contributed to the progress of sciences in the field of health.

Activities

Defensa de tesi "Neuropathological and molecular alterations in a novel neuromelanin-producing transgenic mouse model: relevance to Parkinson's disease and brain aging"

Doctoranda: Núria Peñuelas Peñarroya, grup de Recerca de Malalties neurodegeneratives (VHIR) Directors: Dr. Miquel Vila Bover i Dra. Ariadna Laguna Tuset Tutor: Dr. Joan Xavier Comella Carnicé

News

A project led by Laia Ventura, a Vall d'Hebron nurse, wins an award from the General Council of Nursing

The work "Family presence during invasive procedures in pediatrics: perceptions, attitudes and practices of nurses" has received the Research Award of the General Council of Nursing in the category of Young Promises in Nursing Research.

News

Vall d’Hebron renews its accreditation as a centre committed to excellence in nursing

The recognition awards the Health Care Research Unit the prestigious RNAO and acknowledges the Hospital’s contribution and commitment to implementing the Best Practice Guidelines.

News

Colorectal cancers raise defensive barrier in response to chemotherapy

Dr. Gerard Cantero, who is now a researcher at the CIBBIM-Nanomedicine -Kidney Physiopathology at VHIR, participated in the work led by CRG and IMIM.

News

Precision medicine and innovation in research, protagonists at the World Cancer Day Conference

The Vall d’Hebron Barcelona Hospital Campus has organised the World Cancer Day Conference as part of World Cancer Day, today, 4 February.

News

Stable nanovesicles for the delivery of microRNA in cancer treatment

It is first proof of concept for the delivery of a tumor-suppressive microRNA for the treatment of neuroblastoma, a highly-aggressive pediatric solid tumor of the peripheral nervous system.

News

Vall d’Hebron participates in RESPONSE, a global phase III clinical trial for the treatment of primary biliary cholangitis

The innovative oral drug could provide a new therapeutic option for people with PBC who have not obtained the recommended therapeutic outcome or who do not tolerate first line therapy and cannot continue their treatment.